Myovant Sciences Ltd.

NYSE: MYOV · Real-Time Price · USD
26.98
-0.01 (-0.04%)
At close: Mar 09, 2023, 10:01 PM

Myovant Sciences Balance Sheet Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2022 FY 2021
Period Ending Mar 31, 2022 Mar 31, 2021
Cash & Equivalents
406.7M 674.49M
Short-Term Investments
27.48M 10.44M
Long-Term Investments
n/a n/a
Other Long-Term Assets
20.96M 7.43M
Receivables
23.3M 3.57M
Inventory
7.58M 2.61M
Other Current Assets
23.08M 13.54M
Total Current Assets
488.14M 704.64M
Property-Plant & Equipment
10.9M 12.96M
Goodwill & Intangibles
n/a n/a
Total Long-Term Assets
31.87M 20.38M
Total Assets
520.01M 725.03M
Account Payables
12.25M 17.81M
Deferred Revenue
135.21M 193.14M
Short-Term Debt
2.15M 1.81M
Other Current Liabilities
135.37M 161.16M
Total Current Liabilities
250.33M 281.34M
Long-Term Debt
365.74M 367.89M
Other Long-Term Liabilities
1.71M 32.39M
Total Long-Term Liabilities
743.16M 797.65M
Total Liabilities
993.49M 1.08B
Total Debt
367.89M 369.7M
Common Stock
2K 2K
Retained Earnings
-1.25B -1.05B
Comprehensive Income
-17.29M -17.29M
Shareholders Equity
-473.48M -353.96M
Total Investments
27.48M 10.44M